Yahoo Web Search

Search results

1. www.ncbi.nlm.nih.gov › pmc › articlesSynovial Sarcoma: A Clinical Review - PMC

   www.ncbi.nlm.nih.gov › pmc › articles

   May 19, 2021 · Synovial sarcomas (SS) represent a unique subset of soft tissue sarcomas (STS) and account for 5–10% of all STS. Synovial sarcoma differs from other STS by the relatively young age at diagnosis and clinical presentation.

   • Author: Aaron M. Gazendam, Snezana Popovic, Sohaib Munir, Naveen Parasu, David Wilson, Michelle Ghert
   • DOI: 10.3390/curroncol28030177

   • Publish Year: 2021
   • Publication: Curr Oncol. 2021 Jun; 28(3): 1909-1920.

2. www.ncbi.nlm.nih.gov › pmc › articlesSystemic Treatment for Adults with Synovial Sarcoma

   www.ncbi.nlm.nih.gov › pmc › articles

   Mar 7, 2018 · Synovial sarcoma (SS) is a rare, yet highly malignant, type of soft tissue sarcoma (STS), for which survival has not improved significantly during the past years. In this review, we focus on systemic treatment in adults. Compared to other STS, SS are relatively chemosensitive.

   • Author: Ingrid M. E. Desar, Emmy D. G. Fleuren, Winette T. A. van der Graaf

   • Publish Year: 2018

3. Videos

   • 

     34:01

     youtube.com

     Synovial Sarcoma 101…Explained by a Soft Tissue Pathologist

     19 Apr 2018

     34.2K views

   • 

     4:06

     youtube.com

     Soft Tissue Sarcomas | FAQ with Dr. Adam Levin

     25 Sep 2017

     114.7K views

   • 

     4:26

     youtube.com

     Synovial Sarcoma: Paige's Mayo Clinic Story

     4 Mar 2016

     38.5K views

   View all

4. www.bmj.com › 342 › 7789Diagnosis and management of soft tissue sarcoma - The BMJ

   www.bmj.com › 342 › 7789

   Although the benefit of treatment in specialist centres is difficult to quantify, it is recommended as best practice. How is suspected soft tissue sarcoma investigated? NICE guidelines recommend that patients with sus-pected soft tissue sarcoma are urgently referred for rapid assessment at a one stop diagnostic clinic where triple

5. www.researchgate.net › publication › 351732367(PDF) Synovial Sarcoma: A Clinical Review - ResearchGate

   www.researchgate.net › publication › 351732367

   May 19, 2021 · Synovial sarcomas have unique genomic characteristics and are driven by a pathognomonic t (X;18) chromosomal translocation and subsequent formation of the SS18:SSX fusion oncogenes.

6. www.ncbi.nlm.nih.gov › pmc › articlesUK guidelines for the management of soft tissue sarcomas

   www.ncbi.nlm.nih.gov › pmc › articles

   Nov 15, 2016 · There are specific recommendations for the management of selected subtypes of disease including retroperitoneal and uterine sarcomas, as well as aggressive fibromatosis (desmoid tumours) and other borderline tumours commonly managed by sarcoma services.

   • Author: Adam Dangoor, Beatrice Seddon, Craig Gerrand, Robert Grimer, Jeremy Whelan, Ian Judson

   • Publish Year: 2016

7. www.nature.com › articles › s41416/024/02674-yUK guidelines for the management of soft tissue sarcomas - Nature

   www.nature.com › articles › s41416/024/02674-y

   May 11, 2024 · This iteration of the guidance, as well as updating the general multidisciplinary management of soft tissue sarcoma, includes specific sections relating to the management of sarcomas at defined...

8. People also ask

   What is a synovial sarcoma?

   • Keywords: clinical review; current concepts; soft tissue sarcoma; synovial sarcoma. Synovial sarcomas (SS) represent a unique subset of soft tissue sarcomas (STS) and account for 5-10% of all STS. Synovial sarcoma differs from other STS by the relatively young age at diagnosis and clinical presentation.

   Synovial Sarcoma: A Clinical Review - PubMed

   pubmed.ncbi.nlm.nih.gov/34069748/

   See all results for this question

   Is synovial sarcoma a subset of Sts?

   • Conclusions Synovial sarcomas (SS) represent a unique subset of STS and account for 5–10% of all STS. Synovial sarcoma differs from other STS by the relatively young age at diagnosis, anatomic location (peri-articular) and clinical presentation (slow-growing, painful lesions).

   Synovial Sarcoma: A Clinical Review - PMC - National Center

   www.ncbi.nlm.nih.gov/pmc/articles/PMC8161765/

   See all results for this question

   How common is synovial sarcoma (SS)?

   • Synovial sarcoma (SS) accounts for 5–10% of all STS [1, 2]. SS is an intriguing disease as, unlike the majority of STS, it can occur at any age and everywhere in the body. The peak incidence is in the 30s and it often presents in the extremities [3 •].

   Systemic Treatment for Adults with Synovial Sarcoma - PMC

   www.ncbi.nlm.nih.gov/pmc/articles/PMC5842271/

   See all results for this question

   How is synovial sarcoma treated?

   • Synovial sarcomas have unique genomic characteristics and are driven by a pathognomonic t (X;18) chromosomal translocation and subsequent formation of the SS18:SSX fusion oncogenes. Surgical excision remains the mainstay of treatment with radiation therapy utilized in high-risk tumors.

   Synovial Sarcoma: A Clinical Review - PMC - National Center

   www.ncbi.nlm.nih.gov/pmc/articles/PMC8161765/

   See all results for this question

9. pubmed.ncbi.nlm.nih.gov › 34069748Synovial Sarcoma: A Clinical Review - PubMed

   pubmed.ncbi.nlm.nih.gov › 34069748

   May 19, 2021 · Abstract. Synovial sarcomas (SS) represent a unique subset of soft tissue sarcomas (STS) and account for 5-10% of all STS. Synovial sarcoma differs from other STS by the relatively young age at diagnosis and clinical presentation.